There is no single sensation that tells you cancer is growing in your body. Most cancers produce no obvious feeling in their earliest stages, and the symptoms that do eventually appear often mimic common, harmless conditions. What matters is recognizing patterns: symptoms that persist, changes that can’t be explained by anything else, and screening tests designed to catch problems before you notice anything at all.
Symptoms That Deserve Attention
Cancer can show up differently depending on where it starts, but certain warning signs cut across many types. A lump or thickening you can feel under the skin, especially in the breast, neck, or groin, is one of the most recognizable. Unexplained weight loss is another strong signal. Clinical guidelines flag a loss of 5% or more of your body weight over 6 to 12 months as worth investigating, particularly in adults over 65. For a 180-pound person, that’s about 9 pounds you didn’t try to lose.
Other signals worth paying attention to include a cough or hoarseness that won’t go away, a change in bowel or bladder habits that lasts more than a few weeks, unusual bleeding (in your stool, urine, or between periods), a sore that doesn’t heal, difficulty swallowing, or persistent pain in one area with no clear cause. Skin changes also matter: a new mole, a mole that changes shape or color, or a wound that refuses to close.
The key word in all of this is “persistent.” A cough that lingers for three weeks is different from one that clears up in five days. Oncologists at Moffitt Cancer Center use a 2 to 3 week rule as a general benchmark: if a symptom like a non-healing mouth sore, unexplained sore throat, ear pain, voice change, or neck mass persists beyond that window without an obvious cause, it warrants evaluation. That doesn’t mean every lingering symptom is cancer. It means the symptom has lasted long enough that you shouldn’t keep brushing it off.
Cancers That Hide Until Late Stages
Some cancers are particularly difficult to catch early because they grow in parts of the body where they don’t produce noticeable symptoms for a long time. Pancreatic cancer is one of the most notorious examples. It rarely causes symptoms until it has already spread to other organs. When signs do appear, they tend to include abdominal pain that radiates to the back, loss of appetite, unintentional weight loss, and jaundice (a yellowing of the skin or eyes). By the time someone experiences these, the cancer is often advanced.
Ovarian cancer follows a similar pattern. Its early symptoms, like bloating, pelvic discomfort, and feeling full quickly, overlap so heavily with everyday digestive issues that they’re easy to dismiss. This is one reason screening matters so much for cancers that don’t announce themselves early.
Routine Screening Catches What Symptoms Miss
Screening tests look for cancer in people who feel perfectly fine. They’re your best tool for catching a problem early, when treatment is most effective. Current recommendations from the U.S. Preventive Services Task Force include:
- Breast cancer: Mammograms every two years for women aged 40 to 74.
- Colorectal cancer: Screening starting at age 45 for all adults, continuing through age 75. This can be a colonoscopy, stool-based test, or other approved method.
- Lung cancer: Annual low-dose CT scans for adults aged 50 to 80 who have a 20 pack-year smoking history and currently smoke or quit within the past 15 years.
- Cervical cancer: Pap smears and HPV testing on a regular schedule starting in early adulthood.
These aren’t arbitrary. They’re built on decades of data showing that catching these specific cancers early dramatically improves outcomes. If you’re in the recommended age range and haven’t been screened, that’s the single most useful step you can take.
How Doctors Investigate a Suspected Cancer
If something suspicious turns up on a screening test or you report a concerning symptom, the process typically moves through a few stages: blood work, imaging, and possibly a biopsy.
Blood Tests and Tumor Markers
Standard blood work can reveal clues like unexplained anemia, abnormal liver function, or elevated calcium, all of which can point toward cancer depending on the context. Beyond routine panels, doctors sometimes order tumor marker tests. These measure proteins or other substances that certain cancers release into the blood. PSA is used for prostate cancer, CA-125 for ovarian cancer, and CEA for colorectal cancer, among others.
Tumor markers have real limitations, though. Elevated PSA can come from a benign enlarged prostate. CA-125 can spike from endometriosis or even a menstrual period. These tests are most useful for tracking a known cancer’s response to treatment or watching for recurrence. On their own, they rarely provide a definitive diagnosis.
Imaging Scans
CT scans and MRIs show detailed pictures of your anatomy, revealing masses, enlarged lymph nodes, or organs that look abnormal. They’re good at finding something that shouldn’t be there, but they can’t always tell you whether that something is cancerous.
PET scans work differently. Instead of showing anatomy, they show metabolic activity. You receive a tracer made from a modified sugar molecule. Cancer cells burn through glucose at a much higher rate than normal cells because they have elevated levels of glucose transporters on their surfaces. The modified sugar gets pulled into these hungry cells and becomes trapped there, lighting up as “hot spots” on the scan. This makes PET scans especially useful for distinguishing active tumors from scar tissue or benign growths, and for checking whether cancer has spread to other parts of the body. Many facilities now combine PET and CT into a single scan, layering metabolic data onto an anatomical map.
Biopsy: The Definitive Answer
Imaging and blood tests can raise or lower suspicion, but a biopsy is what confirms a cancer diagnosis. It involves removing a small sample of tissue so a pathologist can examine the cells under a microscope.
A needle biopsy is the most common approach. A doctor inserts a thin needle through the skin to collect cells from a suspicious area, sometimes using ultrasound or CT guidance to reach spots deep inside the body like the liver, lung, or prostate. If the area can’t be reached with a needle, or if needle results come back inconclusive, a surgical biopsy may be needed. This involves making an incision to access the tissue directly, and in some cases the surgeon removes the entire suspicious mass during the same procedure.
Multi-Cancer Blood Tests: A New Option
A newer category of blood tests aims to detect dozens of cancer types from a single draw by looking for fragments of tumor DNA or other molecular signals circulating in the bloodstream. The most studied of these, called Galleri, reported a specificity of 99.5%, meaning false positives are rare. But its sensitivity, the ability to correctly identify people who do have cancer, was only about 51.5% in a large case-control study, and dropped to roughly 21% in a more representative screening population. Detection was especially poor for early-stage cancers, which is exactly when you’d want to catch them.
Other tests in development have shown varying results. CancerSEEK detected about 62% of cancers in a controlled study but only 27% in a real-world trial of nearly 10,000 women, with early-stage detection falling to around 13%. These tests may eventually become a useful supplement to standard screening, but right now they miss too many early cancers to replace colonoscopies, mammograms, or CT scans.
Why Early Detection Changes Everything
The gap between catching cancer early and catching it late is enormous. When breast cancer is found while still localized, the five-year survival rate is 99.3%. For melanoma caught early, it’s 99.6%. Even ovarian cancer, which is notoriously hard to detect, has a 92.4% five-year survival rate when found before it spreads.
Not every cancer follows this pattern. Pancreatic cancer has a five-year survival rate of 44.3% even when localized, and brain cancer sits at 36%. But for the majority of common cancers, the survival difference between localized and advanced disease is stark enough to make screening and early symptom evaluation genuinely life-altering decisions.
You won’t feel cancer growing in most cases. The path to catching it early runs through knowing which symptoms shouldn’t be ignored, staying current on recommended screenings for your age, and not waiting months to have something checked when it doesn’t resolve on its own.